Eisenmenger Syndrome and Endometrial Carcinoma—A Cardio-Oncologic Therapeutic Dilemma: Case Report

Clicks: 5
ID: 314647
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #24 of 261 articles by views in European Heart Journal - Case Reports

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 261 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background Eisenmenger syndrome (ES) represents the end stage of uncorrected congenital heart defects with long-standing left-to-right shunts that evolve into irreversible pulmonary vascular remodeling and pulmonary arterial hypertension (PAH). This report highlights the complex cardio-oncological management of a patient with ES and chronic thromboembolic pulmonary hypertension (CTEPH), who developed endometrial carcinoma complicated by life-threatening uterine bleeding. Case Summary A 66-year-old woman with an uncorrected ostium secundum atrial septal defect complicated by Eisenmenger physiology and CTEPH presented with vaginal bleeding. She was diagnosed with endometrioid adenocarcinoma. Due to prohibitive surgical risk, radiotherapy was selected as the primary treatment; however, bleeding persisted despite completion of 28 sessions. Interruption of warfarin therapy was contraindicated, given her high thrombotic risk. Following multidisciplinary team (MDT) deliberation, uterine artery embolization (UAE) was performed successfully, achieving hemorrhage control without major hemodynamic instability. This minimally invasive intervention proved life-saving in a patient for whom both surgical and medical alternatives carried unacceptable risk. Discussion The case exemplifies the intricate balance between anticoagulation and hemorrhagic control in ES complicated by malignancy. Severe hypoxemia and hemostatic abnormalities inherent to ES amplify both bleeding and thrombotic risks, complicating oncological management. Tumor hypoxia secondary to chronic cyanosis may contribute to radioresistance and poor response to local therapy. The successful use of UAE underscores the vital role of a multidisciplinary cardio-obstetric-oncology team in navigating life-threatening clinical conflicts and tailoring individualized strategies when conventional guidelines offer limited direction.
Reference Key
openalex_W7162092899 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Matheus Henrique Sicupira Lima, Ana Maria Thomaz, Isabella de Luna Kalil, Gustavo Foronda, Ana Cristina Sayuri Tanaka, Luís Henrique Wolff Gowdak, Maria do PAtrocínio Tenório Nunes, Ana Carolina Buso Faccinetto
Journal European Heart Journal - Case Reports
Year 2026
DOI
10.1093/ehjcr/ytag374
URL
https://doi.org/10.1093/ehjcr/ytag374
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.